Pregnant women presenting with a rash illness, or who have been in contact with rash illnesses should be managed as per: Guidance on the investigation, diagnosis and management of viral illness, or exposure to viral rash illness, in pregnancy (publishing.service.gov.uk).
Included in this guidance is the following (section 3.2.3):
“Neonates born to measles infected mothers Human normal immunoglobulin (HNIG) is recommended for neonates born to mothers who develop a measles rash 6 days before to 6 days after delivery. For neonates and infants exposed to measles, HNIG is recommended for up to and including 8 months of age. The dosage for infants is described in the National measles guidelines.”
Measles resources for health care professionals
Measles: guidance, data and analysis
The symptoms, diagnosis, management, surveillance and epidemiology of measles. Contains an excellent slide sets for maternity services and paediatrics - GOV.UK (www.gov.uk).
Local Health Protection Teams
The local Health Protection Team (details can be found at www.gov.uk/health-protection-team) can provide urgent assistance, risk assessment and advice on post exposure prophylaxis.
Information for HCPs
- Measles: information and poster for health professionals
- MMR (measles, mumps, rubella) vaccine: advice for pregnant women
RCPCH measles update webinar
In this webinar, Dr Elizabeth Whittaker, Professor Shamez Ladhani and Nalini Iyanger will provide an essential update on measles in children, ahead of an outbreak.